US$ 27.95
glp-1 drugs and anxiety The risk of depression, anxiety, suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy People with pre-existing depression or
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 523.Macfarlane W.M., Frayling T.M., Ellard S., Evans J.C., Allen L.I., Bulman M.P
found exendin-4 increased the expression of BDNF in mouse neocortex (178)
I think knowing that going in, while understanding the current side effects of GLP-1s, is your best tool for making a decision about the medication. Published August 2025

For the studys main combined adverse outcome of substance-related emergency department visits, hospital admissions, or death, this worked out to about 12 fewer serious events for every 1,000 people treated over 3 years
